Cefepime Induced Encephalopathy Mimicking Acute Stroke
Journal of the Korean Neurological Association
;
: 372-375, 2019.
Article
in Korean
| WPRIM
| ID: wpr-766822
ABSTRACT
Cefepime is a fourth-generation cephalosporin, developed in 1994, and is well known for its adverse effects. In 2002, the Food and Drug Administration adjusted the labeling to account for increased risk of seizures, encephalopathy and myoclonus, especially in the setting of renal impairment. Here we present a case of an 86-year-old female, undergoing Cefepime treatment, with encephalopathy mimicking acute stroke.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Seizures
/
United States Food and Drug Administration
/
Brain Diseases
/
Stroke
/
Myoclonus
Limits:
Aged
/
Aged80
/
Female
/
Humans
Language:
Korean
Journal:
Journal of the Korean Neurological Association
Year:
2019
Type:
Article
Similar
MEDLINE
...
LILACS
LIS